Highlighted videos
QCI Interpret for Oncology
Clinician’s Roundtable: Interpreting genomic test results for precision oncology
You’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and...
QCI Interpret for Oncology
Real-World Applications of Clinical Metagenomic Sequencing in Cancer and...
Clinical metagenomic next-generation sequencing (mNGS), the comprehensive analysis of microbial and...
QIAGEN IPA
QIAGEN IPA
Venn diagrams and merging datasets using QIAGEN Ingenuity Pathway Analysis (IPA)
Based on recent feedback, we are hosting this 60 minute training focused on...
QIAGEN IPA
Beyond discovery_Invest in your research with QIAGEN
It’s a tough time to be in research, but QIAGEN is committed to bringing more...
QIAGEN IPA
QIAGEN IPA new user training
Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in...
QIAGEN IPA
Compare and contextualize results using QIAGEN Ingenuity Pathway Analysis
Take your IPA analysis results to the next level by comparing them to your...
QIAGEN CLC Genomics
QIAGEN CLC Genomics
Multimodal panels analysis using QIAGEN CLC Genomics Workbench
This training will go over how QIAGEN CLC Genomics Workbench can be used to...
QIAGEN CLC Genomics
DNA-seq (whole genome, whole exome, DNA-panel) analyses using QIAGEN CLC Genomics Workbench
In this training, we’ll go over how to easily perform DNA-seq (specifically...
QIAGEN CLC Genomics
Isolate Typing, Strain Identification and Antimicrobial Resistance Analyses Using CLC Genomics Workbench
QIAGEN CLC Genomics Workbench provides tools and workflows for a broad range...
QIAGEN CLC Genomics
Workflow construction and customization using QIAGEN CLC Genomics Workbench
Recently we have received some requests from CLC users (as well as CLC...
QIAGEN OmicSoft and Biomedical Knowledge Base
QIAGEN OmicSoft and Biomedical Knowledge Base
Beyond discovery_Invest in your research with QIAGEN
It’s a tough time to be in research, but QIAGEN is committed to bringing more...
QIAGEN OmicSoft and Biomedical Knowledge Base
Optimizing mouse model selection with OmicSoft Explorer and Studio
Join us for an insightful webinar where you'll discover how to navigate...
QIAGEN OmicSoft and Biomedical Knowledge Base
Identifying new drug targets and biomarkers for a disease of interest using knowledge graphs
QIAGEN Biomedical KB-HD is the high-quality, expert-curated biomedical...
QIAGEN OmicSoft and Biomedical Knowledge Base
Gene set enrichment, target validation and Python-based ‘omics data mining
Learn how to take advantage of QIAGEN Biomedical KB-HD, the high-quality,...
日本語 (Japanese)
日本語 (Japanese)
01. QIAGEN OmicSoft チュートリアル1 概要
OmicSoft の概要と製品の種類についての説明です。
日本語 (Japanese)
02. QIAGEN OmicSoftチュートリアル2 起動と Land の選択
起動後、まず最初に利用するLand を選択します。
日本語 (Japanese)
03. QIAGEN OmicSoftチュートリアル3 グループ分け (Y軸の分類）
表示されているグラフのY軸は疾患の種類、喫煙歴等様々なメタデータで分類できます。
日本語 (Japanese)
04. QIAGEN OmicSoftチュートリアル4 遺伝子の検索、サンプルの絞り込み
単一遺伝子の検索、および様々なメタデータでサンプルの絞り込みを行う方法を解説します。
QCI Interpret for Oncology
QCI Interpret for Oncology
Streamline clinical reporting for high-throughput oncology NGS testing with QCI Interpret One
With the rising demand for personalized cancer treatments, clinical...
QCI Interpret for Oncology
How to accelerate your clinical reporting workflow for high-throughput oncology NGS testing
As the demand for personalized cancer treatment grows, clinical diagnostic...
QCI Interpret for Oncology
The Implementation Journey of Comprehensive Cancer Genome Profiling and Liquid Biopsy in South East Asia
This session traces the evolution of comprehensive cancer genome profiling...
QCI Interpret for Oncology
Benefits of integrating targeted next-generation sequencing (NGS) panels into molecular diagnostics of solid tumors
Variant detection of multiple genes from a single tumor sample requires...
Gene Variant Databases
Gene Variant Databases
HGMD Pro in action: Search, curate and classify genetic variants - Session 1
As the use of next-generation sequencing (NGS) in diagnostics increases, so...
Gene Variant Databases
Germline and Somatic Variant Investigation using COSMIC, HGMD and QCI-IT
The accurate identification and annotation of germline and somatic variants...
Gene Variant Databases
Advances in Genomic Testing for Rare Disease Diagnostics
Over the past decade, whole-exome and whole-genome sequencing have...
Gene Variant Databases
Leveraging expert-curated knowledge from COSMIC and QIAGEN to avoid pitfalls, qualify candidate drug targets, and accelerate early discovery
The cancer drug discovery landscape is shifting. While research continues to...
QCI Interpret for Hereditary
QCI Interpret for Hereditary
Screening 100,000 newborns using whole genome sequencing: The Genomics England Generation Study
In this on-demand recording from ACMG 2024, hear from Dr. David Bick,...
QCI Interpret for Hereditary
QCI Interpret for Hereditary Disorders
Clinical labs face significant challenges in interpreting germline variants...
QCI Secondary Analysis
QCI Secondary Analysis
How decentralized and small labs can adopt high-throughput NGS analysis with limited time and resource investment
Next-generation sequencing (NGS) has rapidly gained popularity as a...
QCI Secondary Analysis
Introducing QCI Secondary Analysis
Introducing QCI Secondary Analysis, a new cloud-based service for NGS...
Pharmacogenomic Insights (PGXI)
Pharmacogenomic Insights (PGXI)
A game-changer for pharmacogenomics: One tool to decode drug response to variation in the genome
Each year, more than 134 million patients experience adverse drug events,...
Cancer Drug Discovery
Cancer Drug Discovery
Single-cell RNA-seq, cell hashing and spatial transcriptomics
In this training, you will learn how to analyze and interpret your own single...
Cancer Drug Discovery
Targeting MUC16 Neoantigens in Pancreatic Cancer: Precision Oncology and Indication Selection
This webinar shows how we enable identification and prioritization of a novel...
Cancer Drug Discovery
Data curation as a key element in successful data science strategy
Learn the 7 habits of effective manual curation that QIAGEN Digital Insights...
Cancer Drug Discovery
Exploring drug response in low-grade glioma
This webinar introduces the Tumor Microenvironment (TME) Pathway in QIAGEN’s...